產品詳情
簡單介紹：
Anti-phospho-Bid (Ser65)抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-phospho-Bid (Ser65)抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-phospho-Bid (Ser65)
Cat. Number:
Anti-phospho-Bid (Ser65)抗體KL-5230R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Bid, a BH3 domain containing proapoptotic Bcl2 family member, is localized in the cytosolic fraction of cells as an inactive precursor. Its active form is generated upon proteolytic cleavage by caspase 8 in the Fas signalingAnti-phospho-Bid (Ser65)抗體 pathway. Cleaved Bid translocates to mitochondria and releases its potent proapoptotic activity, which in turn induces cytochrome c release and mitochondrial damage. The cytochrome c releasing activity of Bid was antagonized by Bcl2. Mutation in the SH3 domain can diminish the cytochrome c releasing activity. In animal model studies, Bid deficient mice are found resistant to the lethal effects of death factor signals relayed through Fas.
Also known as:
Bid (phospho S65); Anti-phospho-Bid (Ser65)抗體p-Bid (phospho S65); BH3 interacting domain death agonist; p22 BID; BID;) BH3-interacting domain death agonist; AltName: BH3-interacting domain death agonist p15; BH3-interacting domain death agonist p13; p13 BID; BH3-interacting domain death agonist p11; p11 BID.
Specificity:
●
Rabbit Polyclonal IgG,Anti-phospho-Bid (Ser65)抗體 affinity purified by Protein A.
●
Reacts with: Rat, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from rat Bid around the phosphorylation site of Ser65.
●
Predicted Molecular Weight: 21kDa.
Storage:
Shipped at 4℃, Anti-phospho-Bid (Ser65)抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl303Mu01 半乳糖凝集素3(GAL3)多克隆抗體 Polyclonal Antibody to Galectin 3 (GAL3)
kl303Ra01 半乳糖凝集素3(GAL3)多克隆抗體 Polyclonal Antibody to Galectin 3 (GAL3)
kl303Rb51 半乳糖凝集素3(GAL3)多克隆抗體 Polyclonal Antibody to Galectin 3 (GAL3)
kl303Si01 半乳糖凝集素3(GAL3)多克隆抗體 Polyclonal Antibody to Galectin 3 (GAL3)
kl304Bo01 半乳糖凝集素4(GAL4)多克隆抗體 Polyclonal Antibody to Galectin 4 (GAL4)
kl304Hu01 半乳糖凝集素4(GAL4)多克隆抗體 Polyclonal Antibody to Galectin 4 (GAL4)
kl304Mu01 半乳糖凝集素4(GAL4)多克隆抗體 Polyclonal Antibody to Galectin 4 (GAL4)
kl304Po01 半乳糖凝集素4(GAL4)多克隆抗體 Polyclonal Antibody to Galectin 4 (GAL4)
kl304Ra01 半乳糖凝集素4(GAL4)多克隆抗體 Polyclonal Antibody to Galectin 4 (GAL4)
kl304Rb51 半乳糖凝集素4(GAL4)多克隆抗體 Polyclonal Antibody to Galectin 4 (GAL4)
kl306Bo01 組織蛋白酶L(CTSL)多克隆抗體 Polyclonal Antibody to Cathepsin L (CTSL)
kl306Fi01 組織蛋白酶L(CTSL)多克隆抗體 Polyclonal Antibody to Cathepsin L (CTSL)
kl306Hu01 組織蛋白酶L(CTSL)多克隆抗體 Polyclonal Antibody to Cathepsin L (CTSL)
kl306Mu01 組織蛋白酶L(CTSL)多克隆抗體 Polyclonal Antibody to Cathepsin L (CTSL)
kl306Po01 組織蛋白酶L(CTSL)多克隆抗體 Polyclonal Antibody to Cathepsin L (CTSL)
kl306Ra01 組織蛋白酶L(CTSL)多克隆抗體 Polyclonal Antibody to Cathepsin L (CTSL)
kl307Hu01 半乳糖凝集素7(GAL7)多克隆抗體 Polyclonal Antibody to Galectin 7 (GAL7)
kl307Mu01 半乳糖凝集素7(GAL7)多克隆抗體 Polyclonal Antibody to Galectin 7 (GAL7)
kl307Ra01 半乳糖凝集素7(GAL7)多克隆抗體 Polyclonal Antibody to Galectin 7 (GAL7)
kl308Bo01 半乳糖凝集素8(GAL8)多克隆抗體 Polyclonal Antibody to Galectin 8 (GAL8)
kl308Hu01 半乳糖凝集素8(GAL8)多克隆抗體 Polyclonal Antibody to Galectin 8 (GAL8)
kl308Mu01 半乳糖凝集素8(GAL8)多克隆抗體 Polyclonal Antibody to Galectin 8 (GAL8)
kl308Po01 半乳糖凝集素8(GAL8)多克隆抗體 Polyclonal Antibody to Galectin 8 (GAL8)
kl308Ra01 半乳糖凝集素8(GAL8)多克隆抗體 Polyclonal Antibody to Galectin 8 (GAL8)
kl309Bo01 半乳糖凝集素9(GAL9)多克隆抗體 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Ca01 半乳糖凝集素9(GAL9)多克隆抗體 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Hu01 半乳糖凝集素9(GAL9)多克隆抗體 Polyclonal Antibody to Galectin 9 (GAL9)
